Physician profile
David L Capaccio
NPI 1457355364
$1,515.12
in general payments reported to CMS, 2019-2025
19 companies · $71.44 in 2025
The $71.44 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $208 · 2021: $283 · 2022: $338 · 2025: $71.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $322.29 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $286.20 | 2019-2022 | |
| Glaxosmithkline, LLC. | $186.04 | 2019 | |
| Pfizer INC. | $146.25 | 2019-2022 | |
| Gilead Sciences, INC. | $114.26 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $108.55 | 2019-2022 | |
| Lilly USA, LLC | $84.59 | 2019-2020 | |
| Abiomed | $47.52 | 2025 | |
| Grifols USA, LLC | $29.58 | 2019 | |
| Novo Nordisk INC | $27.52 | 2019-2020 | |
| Edwards Lifesciences Corporation | $26.32 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.83 | 2019 | |
| Amgen INC. | $24.08 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $18.37 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.30 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $14.76 | 2019 | |
| Amarin Pharma, INC. | $14.15 | 2019 | |
| Abbvie INC. | $13.42 | 2019 | |
| Merck Sharp & Dohme LLC | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Capaccio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.